Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Journal of Medicinal Chemistry|January 27, 2012
Optimization of hydroxybenzothiazoles as novel potent and selective inhibitors of 17β-HSD1Alessandro Spadaro, Martin Frotscher, Rolf W HartmannJournal of Medicinal Chemistry|April 14, 2017
First Dual Inhibitors of Steroid Sulfatase (STS) and 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Designed Multiple Ligands as Novel Potential Therapeutics for Estrogen-Dependent DiseasesMohamed Salah, Ahmed S Abdelsamie, Martin FrotscherMolecular and Cellular Endocrinology|October 19, 2018
Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challengesMohamed Salah, Ahmed S Abdelsamie, Martin FrotscherPlos One|August 23, 2011
Structural basis for species specific inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): computational study and biological validationTobias Klein, Claudia Henn, Matthias Negri, et al.Molecular Informatics|July 28, 2016
Predicting Putative Inhibitors of 17β-HSD1Lennart Heinzerling, Rolf W Hartmann, Martin Frotscher, et al.Plos One|January 14, 2012
Hydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1)Alessandro Spadaro, Matthias Negri, Sandrine Marchais-Oberwinkler, et al.Chemmedchem|July 22, 2014
6-Hydroxybenzothiophene ketones: potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) owing to favorable molecule geometry and conformational preorganizationParisa Miralinaghi, Christian Schmitt, Rolf W Hartmann, et al.Archiv Der Pharmazie|April 26, 2012
Synthesis and biological evaluation of phenyl substituted 1H-1,2,4-triazoles as non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 2Yaseen A Al-Soud, Sandrine Marchais-Oberwinkler, Martin Frotscher, et al.Journal of Medicinal Chemistry|March 3, 2012
Lead optimization of 17β-HSD1 inhibitors of the (hydroxyphenyl)naphthol sulfonamide type for the treatment of endometriosisClaudia Henn, Almuth Einspanier, Sandrine Marchais-Oberwinkler, et al.Molecular and Cellular Endocrinology|November 6, 2008
Development of a biological screening system for the evaluation of highly active and selective 17beta-HSD1-inhibitors as potential therapeutic agentsPatricia Kruchten, Ruth Werth, Sandrine Marchais-Oberwinkler, et al.Pageof 4